Zhang Daqi, Spisani Jerry, Ceriello Arianna, Frattini Francesco, Brucchi Francesco, Dionigi Gianlorenzo, Wan Lanlan, Angileri Alessio Salvatore, Colombo Carla, Ierardi Anna Maria, Carrafiello Gianpaolo
Division of Thyroid Surgery, The China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Jilin Provincial Precision Medicine Laboratory of Molecular Biology and Translational Medicine on Differentiated Thyroid Carcinoma, Changchun, Jilin, China.
Postgraduated School in General Surgery, University of Milan, Milan, Italy.
Front Endocrinol (Lausanne). 2025 Jul 11;16:1445855. doi: 10.3389/fendo.2025.1445855. eCollection 2025.
The finding of liver metastases in thyroid cancer is relatively uncommon. Treatment is complex and depends on several factors, including location, number and size of lesions, associated symptoms, extrahepatic disease and patient's condition. In this context, interventional radiological treatments have been successfully used to optimize disease control or for palliative purposes and have generally been well tolerated. However, careful selection of candidates for such procedures in a multidisciplinary context is crucial.
Front Endocrinol (Lausanne). 2025-7-11
Cochrane Database Syst Rev. 2024-8-9
Cochrane Database Syst Rev. 2017-6-12
J Endocrinol Invest. 2025-3
Endocr Metab Immune Disord Drug Targets. 2024
J Endocrinol Invest. 2023-12
Eur Thyroid J. 2022-10-17
Best Pract Res Clin Endocrinol Metab. 2023-1
Endocr Pathol. 2022-3